FDA approves Nubeqa for non-metastatic castration-resistant prostate cancer July 31, 2019 No Comments
U.S. approval for Otezla to treat oral ulcers associated with Behcet's disease July 22, 2019 No Comments
FDA approves Recarbrio for complicated urinary tract and intra-abdominal infections July 17, 2019 No Comments
FDA grants accelerated approval to Xpovio for relapsed refractory multiple myeloma July 4, 2019 No Comments